Dalfampridine Terminated Phase 3 Trials for Post-Ischemic Stroke Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02422940Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.